Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
David F. Hale Insider Profile
4 Followers
David F. Hale, Director at Biocept, holds 31.30K shares in Oncternal Therapeutics (Ticker: ONCT), holds 656.55K shares in Dermata Therapeutics (Ticker: DRMA), holds 4.01K shares in Biocept (Ticker: BIOCQ). Most recently, David F. Hale Bought ― shares of Oncternal Therapeutics on Feb 27, 2024 for an estimated value of 8.86K.
Profitable Transactions
1 out of 6 Profitable Transactions
Average Return
-20.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that David F. Hale holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jul 02, 2021 - Jul 02, 2022
Return:+77.40%
The most profitable trade made by David F. Hale
David F. Hale's Trading History
Biocept
Dec 10, 2021
Director
Uninformative Sell
1.81K
$501.38
Oncternal Therapeutics
Feb 27, 2024
Director
Informative Buy
8.86K
$258.26K
Dermata Therapeutics
Oct 07, 2022
Director
Uninformative Buy
―
$217.98K
Histogen
Jan 10, 2014
Director
Informative Buy
12.00K
$33.60K
Santarus
Jan 06, 2014
―
Uninformative Sell
10.19M
―
Somaxon Pharmaceuticals
―
―
―
―
List of latest transactions for each holding click on a transaction to see David F. Hale's performance on stock
You May Also Like
David F. Hale insider profile FAQ
What is the percentage of profitable transactions made by David F. Hale?
The percentage of profitable transactions made by David F. Hale is 17%.
What is the average return per transaction made by David F. Hale?
The average return per transaction made by David F. Hale is -20.00%.
What stocks does David F. Hale hold?
David F. Hale holds: BIOCQ, ONCT, DRMA, HSTO, SNTS, SOMX stocks.
What was David F. Hale’s latest transaction?
David F. Hale latest transaction was an Informative Buy of $8.86K.
What was David F. Hale's most profitable transaction?
David F. Hale’s most profitable transaction was an Informative Sell of ONCT stock on July 2, 2021. The return on the trade was 77.40%.
What is David F. Hale's role in Biocept?
David F. Hale's role in Biocept is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.